Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung

References

• Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W., P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature, Phar- macogenetics, 6, 1, 1996.
   Google Scholar
• Guengerich, F. P., Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue, Pharmacol. Ther., 45, 299, 1990.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. J. and Gelboin, H. V., Role of human cytochromes P450 in the metabolic activation of chemi- cal carcinogens and toxins, Drug Metab. Rev., 26, 165, 1994.
   PubMed Web of Science ®Google Scholar
• Foth, H., Role of the lung in accumulation and me- tabolism of xenobiotic compounds - implications for chemically induced toxicity, Crit. Rev. Toxicol., 25, 165, 1995.
   PubMed Web of Science ®Google Scholar
• Kinnula, V. L., Crapo, J. D., and Raivio, K. O., Generation and disposal of reactive oxygen metabo- lites in the lung, Lab. Invest., 73, 3, 1995.
   PubMed Web of Science ®Google Scholar
• Gram, T. E., Chemically reactive intermediates and pulmonary xenobiotic toxicity, Pharmacol. Rev., 49, 297, 1997.
   PubMed Web of Science ®Google Scholar
• d’Errico A., Malats N., Vineis P., and Boffetta P., Review of studies of selected metabolic polymor- phisms and cancer, in Metabolic polymorphisms and susceptibility to cancer, Vineis, P., Malats, N., Lang, M., d’Errico, A., Caporaso, N., Cuzick, J., and Boffetta, P., Eds., IARC Scientific Publications No. 148, Lyon, 1999, 323.
   Google Scholar
• Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., and Alexandrov, K., Genetic polymorphisms of CYP genes, alone or in combination, as a risk modi-fier of tobacco-related cancers, Cancer Epidemiol. Biomarkers Prev., 9, 3, 2000.
   PubMed Web of Science ®Google Scholar
• Smith, G. B. J., Harper, P. A., Wong, J. M. Y., Lam, M. S. M., Reid, K. R., Petsikas, D., and Massey, T. E., Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms, Cancer Epidemiol. Biomarkers Prev., 10, 839, 2001.
   Google Scholar
• Buckpitt A.and Cruikshank M., Biochemical func- tion of the lungs: metabolism of xenobiotic agents, in Toxicology of the Respiratory System, Roth, R., Ed., Elsevier, New York, 1997, 159.
   Google Scholar
• Bogdanffy M. S.and Keller D. A., Metabolism of xenobiotics by the respiratory tract, in Toxicology of the lung, Gardner, D. E., Crapo, J. D., and McClellan, R. O., Eds., Taylor & Francis, Washington D.C., 1999, 85.
   Google Scholar
• Capdevila, J. H., Falck, J. R., and Harris, R. C., Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase, J. Lipid Res., 41, 163, 2000.
   PubMed Web of Science ®Google Scholar
• Jacobs, E. R. and Zeldin, D. C., The lung HETEs (and EETs) up, Am. J. Physiol. Heart Circ. Physiol., 280, H1–H10, 2001.
   PubMed Web of Science ®Google Scholar
• Tesfaigzi, Y., Kluger, M., and Kozak, W., Clinical and cellular effects of cytochrome P-450 modulators, Respir. Physiol., 128, 79, 2001.
   PubMedGoogle Scholar
• Lame, M. W., Jones, A. D., Morin, D., Wilson, D. W., and Segall, H. J., Association of dehydromonocrotaline with rat red blood cells, Chem. Res Toxicol., 10, 694, 1997.
   PubMed Web of Science ®Google Scholar
• Pan, L. C., Lame, M. W., Morin, D., Wilson, D. W., and Segall, H. J., Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung prepara- tions, Toxicol. Appl. Pharmacol., 110, 336, 1991.
   PubMed Web of Science ®Google Scholar
• Raunio, H., Hakkola, J., Hukkanen, J., Lassila, A., Päivärinta, K., Pelkonen, O., Anttila, S., Piipari, R., Boobis, A. R., and Edwards, R. J., Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue, Exp. Toxic. Pathol., 51, 412, 1999.
   PubMedGoogle Scholar
• Dahl, A. R. and Lewis, J. L., Respiratory tract uptake of inhalants and metabolism of xenobiotics, Annu. Rev. Pharmacol. Toxicol., 32, 383, 1993.
   Google Scholar
• Gerde, P., Muggenburg, B. A., Thornton-Manning, J. R., Lewis, J. L., Pyon, K. H., and Dahl, A. R., Benzo[]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in, tracheal epithelium, Carcinogenesis, 18, 1825, 1997.
   PubMed Web of Science ®Google Scholar
• Gerde, P., Muggenburg, B. A., Scott, G. G., Lewis, J. L., Pyon, K. H., and Dahl, A. R., Local metabo- lism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposure, Carcinogenesis, 19, 493, 1998.
   PubMed Web of Science ®Google Scholar
• Gerde, P., Muggenburg, B. A., Stephens, T., Lewis, J. L., Pyon, K. H., and Dahl, A. R., A relevant dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is extensively metabolised and rapidly absorbed in the canine tracheal mucosa, Cancer Res., 58, 1417, 1998.
   PubMed Web of Science ®Google Scholar
• Kapitulnik, J., Wislocki, P. G., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H., Tumorigenity stud- ies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha- epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice, Cancer Res., 38, 354, 1978.
   Google Scholar
• Gerde, P., Muggenburg, B. A., Lundborg, M., and Dahl, A. R., The rapid alveolar absorption of diesel soot-adsorbed benzo[a]pyrene: bioavailability, metabo- lism and dosimetry of an inhaled particle-borne car- cinogen, Carcinogenesis, 22, 741, 2001.
   PubMed Web of Science ®Google Scholar
• Hecht, S. S., Tobacco smoke carcinogens and lung cancer, J. Natl. Cancer Inst., 91, 1194, 1999.
   Google Scholar
• Upadhyaya, P., Kenney, P. M., Hochalter, J. B., Wang, M., and Hecht, S. S., Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)- 1- butanol enantiomers and metabolites in the A/J mouse, Carcinogenesis, 20, 1577, 1999.
   Google Scholar
• Autrup, H., Carcinogen metabolism in cultured hu- man tissues and cells, Carcinogenesis, 11, 707, 1990.
   Google Scholar
• Roth, R. A. and Vinegar, A., Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition, Pharmacol. Ther., 48, 143, 1990.
   PubMed Web of Science ®Google Scholar
• Zeldin, D. C., Foley, J., Ma, J., Boyle, J. E., Pascual, J. M., Moomaw, C. R., Tomer, K. B., Steenbergen, C., and Wu, S., CYP2J subfamily P450s in the lung: expression, localization, and potential functional sig- nificance, Mol. Pharmacol., 50, 1111, 1996.
   PubMed Web of Science ®Google Scholar
• Scarborough, P. E., Ma, J., Qu, W., and Zeldin, D. C., P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tis- sues, Drug Metab Rev., 31, 205, 1999.
   PubMed Web of Science ®Google Scholar
• Krishna, D. R. and Klotz, U., Extrahepatic metabo- lism of drugs in humans, Clin. Pharmacokinet., 26, 144, 1994.
   PubMed Web of Science ®Google Scholar
• West, J. A., Pakehham, G., Morin, D., Fleschner, C. A., Buckpitt, A. R., and Plopper, C. G., Inhaled naphthalene causes dose dependent Clara cell cyto- toxicity in mice but not in rats, Toxicol. Appl. Pharmacol., 173, 114, 2001.
   PubMed Web of Science ®Google Scholar
• Ritter, J. K., Owens, I. S., Negishi, M., Nagata, K., Sheen, Y. Y., Gillette, J. R., and Sasame, H. A., Mouse pulmonary cytochrome P-450 naphthalene hydroxylase: cDNA cloning, sequence, and expres- sion in Saccharomyces cerevisiae, Biochemistry, 30, 11430, 1991.
   Google Scholar
• Schultz, M. A., Morin, D., Chang, A. M., and Buckpitt, A., Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abun- dance in mouse lung subcompartments, J. Pharmacol. Exp. Ther., 296, 510, 2001.
   Google Scholar
• Lanza, D. L., Code, E., Crespi, C. L., Gonzalez, F. J., and Yost, G. S., Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by re- combinant human CYP2F1 expressed in lymphoblastoid cells., Drug Metab. Dispos., 27, 798, 1999.
   PubMed Web of Science ®Google Scholar
• Watt, K. C. and Buckpitt, A. R., Species differences in the regio- and stereoselectivity of 1- nitronaphthalene metabolism, Drug Metab Dispos., 28, 376, 2000.
   PubMed Web of Science ®Google Scholar
• Yost G. S., Selected, nontherapeutic agents, in Com- prehensive Toxicology, Roth, R., Ed., Elsevier, New York, 1999, 591.
   Google Scholar
• Lanza, D. L. and Yost, G. S., Selective dehydroge- nation/oxygenation of 3-methylindole by cytochrome P450 enzymes, Drug Metab. Dispos., 29, 950, 2001.
   PubMed Web of Science ®Google Scholar
• Yost, G. S., Mechanisms of 3-methylindole pneumotoxicity, Chem. Res Toxicol., 2, 273, 1989.
   Google Scholar
• Czerwinski, M., McLemore, T. L., Philpot, R. M., Nhamburo, P. T., Korzekwa, K., Gelboin, H. V., and Gonzalez, F. J., Metabolic activation of 4- ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism, Cancer Res., 51, 4636, 1991.
   PubMed Web of Science ®Google Scholar
• Lakhanpal, S., Donehower, R. C., and Rowinsky, E. K., Phase II study of 4-ipomeanol, a naturally occur- ring alkylating furan, in patients with advanced hepato- cellular carcinoma, Invest. New Drugs, 19, 69, 2001.
   PubMed Web of Science ®Google Scholar
• Born, S. L., Fix, A. S., Caudill, D., and Lehman- McKeeman, L. D., Selective Clara cell injury in mouse lung following acute administration of coumarin, Toxicol. Appl. Pharmacol., 151, 45, 1998.
   PubMed Web of Science ®Google Scholar
• Dahl, G. A., Miller, E. C., and Miller, J. A., Compara- tive carcinogenicities and mutagenicities of vinyl carbam- ate, ethyl carbamate, and ethyl N-hydroxycarbamate, Cancer Res., 40, 1194, 1980.
   Google Scholar
• Forkert, P.-G. and Lee, R. P., Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A, Toxicol. Appl. Pharmacol., 146, 245, 1997.
   PubMed Web of Science ®Google Scholar
• Forkert, P.-G., Lee, R. P., and Reid, K., Involve- ment of CYP2E1 and carboxyesterase enzymes in vinyl carbamate metabolism in human lung mi- crosomes, Drug Metab. Dispos., 29, 258, 2001.
   Google Scholar
• Dowsley, T. F., Reid, K., Petsikas, D., Ulreich, J. B., Fisher, R. L., and Forkert, P.-G., Cytochrome P- 450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver mi- crosomes, J. Pharmacol. Exp. Ther., 289, 641, 1999.
   PubMed Web of Science ®Google Scholar
• Dowsley, T. F., Ulreich, J. B., Bolton, J. L., Park, S. S., and Forkert, P. G., CYP2E1-dependent bioactivation of 1,1-dichloroethylene in murine lung: formation of reactive intermediates and glutathione conjugates, Toxicol. Appl. Pharmacol., 139, 42, 1996.
   PubMed Web of Science ®Google Scholar
• Forkert, P. G., 1,1-Dichloroethylene-induced Clara cell damage is associated with in situ formation of the reactive epoxide. Immunohistochemical detection of its glutathione conjugate, Am. J Respir. Cell Mol. Biol., 20, 1310, 1999.
   Google Scholar
• Green, T., Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action, Environ. Health Perspect., 108 (Suppl. 2), 261, 2000.
   Google Scholar
• Wheeler, C. W. and Guenthner, T. M., Cytochrome P-450-dependent metabolism of xenobiotics in hu- man lung, J. Biochem. Toxicol., 6, 163, 1991.
   PubMedGoogle Scholar
• Raunio H., Pasanen M., Mäenpää J., Hakkola J., and Pelkonen O., Expression of extrahepatic cyto-chrome P450 in humans, in Advances in Drug Me- tabolism in Man, Pacifici, G. M., and Fracchia, G. N., Eds., European Commission, Office for Official Pub- lications of the European Communities, Luxembourg, 1995, 234.
   Google Scholar
• Wheeler, C. W. and Guenthner, T. M., Spectro- scopic quantitation of cytochrome P-450 in human lung microsomes, J. Biochem. Toxicol., 5, 269, 1990.
   PubMedGoogle Scholar
• Shimada, T., Yun, C.-H., Yamazaki, H., Gautier, J.-C., Beaune, P. H., and Guengerich, F. P., Char- acterization of human lung microsomal cytochrome P-4501A1 and its role in the oxidation of chemical carcinogens, Mol. Pharmacol., 41, 856, 1992.
   Google Scholar
• Shou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., and Gelboin, H. V., The role of 12 cDNA-ex- pressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-diol., Mol. Carcinog., 10, 159, 1994.
   PubMed Web of Science ®Google Scholar
• Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R., Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1, Cancer Res., 56, 2979, 1996.
   Google Scholar
• Omiecinski, C. J., Redlich, C. A., and Costa, P., Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues, Cancer Res., 50, 4315, 1990.
   PubMed Web of Science ®Google Scholar
• McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., Lubet, R. A., Eggleston, J. C., Boyd, M. R., and Hines, R. N., Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas, J. Natl. Cancer Inst., 83, 1333, 1990.
   Google Scholar
• Wheeler, C. W., Park, S.-S., and Guenthner, T. M., Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes, Mol. Pharmacol., 38, 643, 1990.
   PubMed Web of Science ®Google Scholar
• Anttila, S., Hietanen, E., Vainio, H., Camus, A.-M., Gelboin, H. V., Park, S. S., Heikkilä, L., Karjalainen, A., and Bartsch, H., Smoking and peripheral type of cancer are related to high levels of pulmonary cyto- chrome P450IA in lung cancer patients, Int. J. Cancer, 47, 681, 1991.
   PubMed Web of Science ®Google Scholar
• Anttila, S., Vainio, H., Hietanen, E., Camus, A.-M., Malaveille, C., Brun, G., Husgafvel-Pursiainen, K., Heikkilä, L., Karjalainen, A., and Bartsch, H., Immunohistochemical detection of pulmonary cyto- chrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients, Environ. Health Perspect., 98, 179, 1992.
   Google Scholar
• Bartsch, H., Castegnaro, M., Rojas, M., Camus, A.-M., Alexandrov, K., and Lang, M., Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for to- bacco-related lung cancer, Toxicol. Lett., 64-65, 477, 1992.
   Google Scholar
• Mollerup, S., Ryberg, D., Hewer, A., Phillips, D. H., and Haugen, A., Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients, Cancer Res., 59, 3317, 1999.
   PubMed Web of Science ®Google Scholar
• Anttila, S., Tuominen, P., Hirvonen, A., Nurminen, M., Karjalainen, A., Hankinson, O., and Elovaara, E., CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydro- carbon receptor, Pharmacogenetics, 11, 501, 2001.
   PubMedGoogle Scholar
• Petruzzelli, S., Camus, A.-M., Carrozzi, L., Ghelarducci, L., Rindi, M., Menconi, G., Angeletti, C. A., Ahotupa, M., Hietanen, E., Aitio, A., Saracci, R., Bartsch, H., and Giuntini, C., Long-lasting ef- fects of tobacco smoking on pulmonary drug-metabo- lizing enzymes: a case-control study on lung cancer patients, Cancer Res., 48, 4695, 1988.
   PubMed Web of Science ®Google Scholar
• Cheng, Y., Chen, C., Lin, P., Huang, K. H., Lin, T., Wu, M., and Lee, H., DNA adduct level in lung tissue may act as a risk biomarker of lung cancer, Eur. J. Cancer, 1381, 2000.
   Google Scholar
• Kawajiri K., CYP1A1, in Metabolic polymorphisms and susceptibility to cancer, Vineis, P., Malats, N., Lang, M., d’Errico, A., Caporaso, N., Cuzick, J., and Boffetta, P., Eds., IARC Scientific Publications No. 148, Lyon, 1999, 159.
   Google Scholar
• Macé, K., Bowman, E. D., Vautravers, P., Shields, P. G., Harris, C. C., and Pfeifer, A. M. A., Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissue, Eur. J. Cancer, 34, 914, 1998.
   Google Scholar
• Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y.-F., Guengerich, F. P., and Inui, Y., Char- acterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs, Drug Metab. Dispos., 24, 515, 1996.
   Google Scholar
• Kelly, J. D., Eaton, D. L., Guengerich, F. P., and Coulombe, R. A., Aflatoxin B1 activation in human lung, Toxicol. Appl. Pharmacol., 144, 88, 1997.
   PubMed Web of Science ®Google Scholar
• Hukkanen, J., Hakkola, J., Anttila, S., Piipari, R., Karjalainen, A., Pelkonen, O., and Raunio, H., Detection of mRNA encoding xenobiotic-metaboliz- ing cytochrome P450s in human broncho-alveolar macrophages and peripheral blood lymphocytes, Mol. Carcinog., 20, 224, 1997.
   PubMed Web of Science ®Google Scholar
• Thum, T. and Borlak, J., Gene expression in distinct regions of the heart, Lancet, 355, 979, 2000.
   PubMed Web of Science ®Google Scholar
• Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J. A., Greenlee, W. F., Burke, M. D., and Melvin, W. T., Tumor-specific expression of cyto- chrome P450 CYP1B1, Cancer Res., 57, 3026, 1997.
   Google Scholar
• Tang, Y. M., Green, B. L., Chen, G.-F., Thompson, P. A., Lang, N. P., Shinde, A., Lin, D.-X., Tan, W., Lyn-Cook, B. D., Hammons, G. J., and Kadlubar, F. F., Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and dis- tribution in prostate cancer cases and controls, Phar- macogenetics, 10, 761, 2000.
   Google Scholar
• Spivack, S. D., Hurteau, G. J., Reilly, A. A., Aldous, K. M., Ding, X., and Kaminsky, L. S., CYP1B1 expression in human lung, Drug Metab. Dispos., 29, 916, 2001.
   PubMed Web of Science ®Google Scholar
• Tang, Y. M., Chen, G.-F., Thompson, P. A., Lin, D.-X., Lang, N. P., and Kadlubar, F. F., Develop- ment of an antipeptide antibody that binds to the C- terminal region of human CYP1B1, Drug Metab. Dispos., 27, 274, 1999.
   Google Scholar
• Willey, J. C., Coy, E., Brolly, C., Utell, M. J., Frampton, M. W., Hammersley, J., Thilly, W. G., Olson, D., and Cairns, K., Xenobiotic metabolism gene expression in human bronchial epithelial and alveolar macrophage cells, Am. J. Respir. Cell Mol. Biol., 14, 262, 1996.
   PubMed Web of Science ®Google Scholar
• Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y.-Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F., Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of a cytochrome that maps to chromosome 2, J. Biol. Chem., 269, 13092, 1994.
   PubMed Web of Science ®Google Scholar
• Willey, J. C., Coy, E. L., Frampton, M. W., Torres, A., Apostolakos, M. J., Hoehn, G., Schuermann, W. H., Thilly, W. G., Olson, D. E., Hammersley, J. R., Crespi, C. L., and Utell, M. J., Quantitative RT- PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers, Am. J. Respir. Cell Mol. Biol., 17, 114, 1997.
   PubMed Web of Science ®Google Scholar
• Piipari, R., Savela, K., Nurminen, T., Hukkanen, J., Raunio, H., Hakkola, J., Mäntylä, T., Beaune, P., Edwards, R. J., Boobis, A. R., and Anttila, S., Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct for- mation in bronchoalveolar macrophages of smokers and non-smokers, Int. J. Cancer, 86, 610, 2000.
   PubMed Web of Science ®Google Scholar
• Crawford, E. L., Weaver, D. A., DeMuth, J. P., Jackson, C. M., Khuder, S. A., Frampton, M. W., Utell, M. J., Thilly, W. G., and Willey, J. C., Mea- surement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells., Carcinogenesis, 19, 1867, 1998.
   PubMed Web of Science ®Google Scholar
• Koskela, S., Hakkola, J., Hukkanen, J., Pelkonen, O., Sorri, M., Saranen, A., Anttila, S., Fernandez- Salguero, P., Gonzalez, F. J., and Raunio, H., Ex- pression of CYP2A genes in human liver and extrahe- patic tissues, Biochem. Pharmacol., 57, 1407, 1999.
   PubMed Web of Science ®Google Scholar
• Hecht, S. S., Biochemistry, biology, and carcinoge- nicity of tobacco-specific N-nitrosamines, Chem. Res. Toxicol., 11, 559, 1998.
   Google Scholar
• Kushida, H., Fujita, K., Suzuki, A., Yamada, M., Endo, T., Nohmi, T., and Kamataki, T., Metabolic activation of N-alkylnitrosamines in genetically engi- neered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase, Carcinogenesis, 21, 1227, 2000.
   PubMed Web of Science ®Google Scholar
• Hecht, S. S., Hochalter, J. B., Villalta, P. W., and Murphy, S. E., 2’-hydroxylation of nicotine by cyto- chrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor, Proc. Natl. Acad. Sci. USA, 97, 12493, 2000.
   Google Scholar
• Miyamoto, M., Umetsu, Y., Dosaka-Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H., Nemoto, N., Sato, K., Ariyoshi, N., and Kamataki, T., CYP2A6 gene deletion reduces susceptibility to lung cancer, Biochem. Biophys. Res. Commun., 261, 658, 1999.
   PubMed Web of Science ®Google Scholar
• Kamataki, T., Nunoya, K., Sakai, Y., Kushida, H., and Fujita, K., Genetic polymorphism of CYP2A6 in relation to cancer, Mutat. Res., 428, 125, 1999.
   Google Scholar
• Tan, W., Chen, G.-F., Xing, D. Y., Song, C.-Y., Kadlubar, F. F., and Lin, D.-X., Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population, Int. J. Cancer, 95, 96, 2001.
   Google Scholar
• Loriot, M.-A., Rebuissou, S., Oscarson, M., Cenee, S., Miyamoto, M., Ariyoshi, N., Kamataki, T., Hemon, D., Beaune, P., and Stucker, I., Genetic polymorphisms of cytochrome P450 2A6 in a case- control study on lung cancer in a French population, Pharmacogenetics, 11, 39, 2001.
   Google Scholar
• Su, T., Bao, Z., Zhang, Q. Y., Smith, T. J., Hong, J.-Y., and Ding, X., Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone, Cancer Res., 60, 5074, 2000.
   Google Scholar
• Gonzalez, F. J., Crespi, C. L., Czerwinski, M., and Gelboin, H. V., Analysis of human cytochrome P450 catalytic activities and expression, Tohoku. J. Exp. Med., 168, 67, 1992.
   PubMed Web of Science ®Google Scholar
• Czerwinski, M., McLemore, T. L., Gelboin, H. V., and Gonzalez, F. J., Quantitation of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors, Cancer Res., 54, 1085, 1994.
   PubMed Web of Science ®Google Scholar
• Runge, D. M., Stock, T. W., Lehmann, T., Taege, C., Bernauer, U., Stolz, D. B., Hofmann, S., and Foth, H., Expression of cytochrome P450 2E1 in normal human bronchial epithelial cells and activa- tion by ethanol in culture, Arch. Toxicol, 75, 335, 2001.
   PubMed Web of Science ®Google Scholar
• Mori, M., Tezuka, F., Chiba, R., Funae, Y., Watanabe, M., Nukiwa, T., and Takahashi, T., Atypical adenomatous hyperplasia and adenocarci- noma of the human lung. Their heterology in form and analogy in immunohistochemical characteristics, Can- cer, 77, 665, 1996.
   Google Scholar
• Gervot, L., Rochat, B., Gautier, J. C., Bohnenstengel, F., Kroemer, H., de Berardinis, V., Martin, H., Beaune, P., and de Waziers, I., Human CYP2B6: expression, inducibility and catalytic activities, Pharmacogenetics, 9, 295, 1999.
   PubMedGoogle Scholar
• Code, E. L., Crespi, C. L., Penman, B. W., Gonzalez, F. J., Chang, T. K. H., and Waxman, D. J., Human cytochrome P4502B6: interindividual hepatic expres- sion, substrate specificity, and role in procarcinogen activation, Drug Metab. Dispos., 25, 985, 1997.
   PubMed Web of Science ®Google Scholar
• McCully, S., Boobis, A., Philpot, R., Borlak, J., and Hawksworth, G., Characterisation of human lung drug-oxidising enzymes, 12th International Sympo- sium on Microsomes and Drug Oxidations,1998, (Abstr.).
   Google Scholar
• Yokose, T., Doy, M., Taniguchi, T., Shimada, T., Kakiki, M., Horie, T., Matsuzaki, Y., and Mukai, K., Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues, Virchows Arch., 434, 401, 1999.
   PubMed Web of Science ®Google Scholar
• Nakajima, T., Elovaara, E., Gonzalez, F. J., Gelboin, H. V., Raunio, H., Pelkonen, O., Vainio, H., and Aoyama, T., Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450, Chem. Res. Toxicol., 7, 891, 1994.
   PubMed Web of Science ®Google Scholar
• Wheeler, C. W., Wrighton, S. A., and Guenthner, T. M., Detection of human lung cytochrome P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA, Biochem. Pharmacol., 44, 911, 1992.
   Google Scholar
• Toussaint, C., Albin, N., Massaad, L., Grunenwald, D., Parise, O., Jr., Morizet, J., Gouyette, A., and Chabot, G. G., Main drug- and carcinogen-metabo- lizing enzyme systems in human non-small cell lung cancer and peritumoral tissues, Cancer Res., 53, 4608, 1993.
   Google Scholar
• Zeldin, D. C., Moomaw, C. R., Jesse, N., Tomer, K. B., Beetham, J., Hammock, B. D., and Wu, S., Biochemical characterization of the human liver cyto- chrome P450 arachidonic acid epoxygenase pathway, Arch. Biochem. Biophys., 330, 87, 1996.
   PubMed Web of Science ®Google Scholar
• Rifkind, A. B., Lee, C., Chang, T. K., and Waxman, D. J., Arachidonic acid metabolism by human cyto- chrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C en- zymes in arachidonic acid epoxygenation in human liver microsomes, Arch. Biochem. Biophys., 320, 380, 1995.
   PubMed Web of Science ®Google Scholar
• Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., and Busse, R., Cyto- chrome P450 2C is an EDHF synthase in coronary arteries, Nature, 401, 493, 1999.
   PubMed Web of Science ®Google Scholar
• Kivistö, K. T., Griese, E.-U., Stuven, T., Fritz, P., Friedel, G., Kroemer, H. K., and Zanger, U. M., Analysis of CYP2D6 expression in human lung: implicationsfor the association between CYP2D6 activity and susceptibility to lung cancer, Pharmacogenetics, 7, 295, 1997.
   PubMedGoogle Scholar
• Huang, Z., Fasco, M. J., Spivack, S., and Kaminsky, L. S., Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues, Cancer Res., 57, 2589, 1997.
   Google Scholar
• Guidice, J.-M. L., Marez, D., Sabbagh, N., Legrand- Andreoletti, M., Spire, C., Alcaide, E., Lafitte, J.- J., and Broly, F., Evidence for CYP2D6 expression in human lung, Biochem. Biophys. Res. Commun., 241, 79, 1997.
   PubMed Web of Science ®Google Scholar
• Saarikoski, S. T., Sata, F., Husgafvel-Pursiainen, K., Rautalahti, M., Haukka, J., Impivaara, O., Järvisalo, J., Vainio, H., and Hirvonen, A., CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour, Pharmacogenetics, 10, 5, 2000.
   Google Scholar
• Rostami-Hodjegan, A., Lennard, M. S., Woods, H. F., and Tucker, G. T., Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson’s disease, Pharmacogenetics, 8, 227, 1998.
   PubMedGoogle Scholar
• Botto, F., Seree, E., Khyari, S. E., de Sousa, G., Massacrier, A., Placidi, M., Cau, P., Pellet, W., Rahmani, R., and Barra, Y., Tissue-specific expres- sion and methylation of the human CYP2E1 gene, Biochem. Pharmacol., 48, 1095, 1994.
   PubMed Web of Science ®Google Scholar
• Kivistö, K. T., Linder, A., Friedel, G., Beaune, P., Belloc, C., Kroemer, H. K., and Fritz, P., Immu- nohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue, Virchows Arch., 426, 243, 1995.
   PubMed Web of Science ®Google Scholar
• Ronis M. J. J., Lindros K. O., and Ingelman- Sundberg M., The CYP2E subfamily, in Cytochromes P450: Metabolic and Toxicological Aspects, Ioannides, C., and Parke, D. V., Eds., CRC Press, Boca Raton, 1996, 211.
   Google Scholar
• Lieber, C. S., Cytochrome P-4502E1: Its physiologi- cal and pathological role, Physiol. Rev., 77, 517, 1997.
   PubMed Web of Science ®Google Scholar
• Yamazaki, H., Inui, Y., Yun, C.-H., Guengerich, F. P., and Shimada, T., Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitro- samines in human liver microsomes, Carcinogenesis, 13, 1789, 1992.
   Google Scholar
• Csanady, G. A., Guengerich, F. P., and Bond, J. A., Comparison of the biotransformation of 1,3-butadi- ene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice, Carcinogenesis, 13, 1143, 1992.
   PubMed Web of Science ®Google Scholar
• Forkert, P.-G., Premdas, P. D., and Bowers, R. J., Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs, Am. J. Respir. Cell Mol. Biol., 23, 687, 2000.
   PubMed Web of Science ®Google Scholar
• Nhamburo, P. T., Kimura, S., McBride, O. W., Kozak, C. A., Gelboin, H. V., and Gonzalez, F. J., The human CYP2F gene family: identification of a cDNA encoding a new cytochrome P450, cDNA- directed expression, and chromosome mapping, Bio- chemistry, 29, 5491, 1990.
   Google Scholar
• Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., and Zeldin, D. C., Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart, J. Biol. Chem., 271, 3460, 1996.
   Google Scholar
• Zeldin, D. C., Plitman, J. D., Kobayashi, J., Miller, R. F., Snapper, J. R., Falck, J. R., Szarek, J. L., Philpot, R. M., and Capdevila, J. H., The rabbit pulmonary cytochrome P450 arachidonic acid meta- bolic pathway: characterization and significance, J. Clin. Invest., 95, 2150, 1995.
   PubMed Web of Science ®Google Scholar
• Birks, E. K., Bousamra, M., Presberg, K., Marsh, J. A., Effros, R. M., and Jacobs, E. R., Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue, Am. J. Physiol., 272, 823, 1997.
   Google Scholar
• Kiss, L., Schütte, H., Mayer, K., Grimm, H., Padberg, W., Seeger, W., and Grimminger, F., Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact human lung vasculature, Am. J. Respir. Crit. Care Med., 161, 1917, 2000.
   PubMed Web of Science ®Google Scholar
• Rylander, T., Neve, E. P. A., Ingelman-Sundberg, M., and Oscarson, M., Identification and tissue dis- tribution of the novel human cytochrome P450 2S1 (CYP2S1), Biochem. Biophys. Res. Commun., 281, 529, 2001.
   PubMed Web of Science ®Google Scholar
• Saarikoski, S. T., Rivera, S. P., and Hankinson, O., Identification of a novel dioxin-inducible cytochrome P450, 12th International Conference on Cytochrome P450, 161, 2001, (Abstr.).
   Google Scholar
• Kivistö, K. T., Fritz, P., Linder, A., Friedel, G., Beaune, P., and Kroemer, H. K., Immunohistochemi- cal localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue, Histochemistry, 103, 25, 1995.
   PubMedGoogle Scholar
• Kivistö, K. T., Griese, E.-U., Fritz, P., Linder, A., Hakkola, J., Raunio, H., Beaune, P., and Kroemer, H. K., Expression of cytochrome P4503A enzymes in human lung: a combined RT-PCR and immunohis- tochemical analysis of normal tissue and lung tumors, Naunyn-Schmiedeberg Arch. Pharmacol., 353, 207, 1996.
   PubMed Web of Science ®Google Scholar
• Anttila, S., Hukkanen, J., Hakkola, J., Stjernvall, T., Beaune, P., Edwards, R. J., Boobis, A. R., Pelkonen, O., and Raunio, H., Expression and local- ization of CYP3A4 and CYP3A5 in human lung, Am. J. Respir. Cell Mol. Biol., 16, 242, 1997.
   PubMed Web of Science ®Google Scholar
• Lechevrel, M., Casson, A. G., Wolf, C. R., Hardie, L. J., Flinterman, M. B., Montesano, R., and Wild, C. P., Characterization of cytochrome P450 expres- sion in human oesophageal mucosa, Carcinogenesis, 20, 243, 1999.
   Google Scholar
• Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P., Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrere, 7,8-dihydroxy-7,8- dihydrobenzo(a)pyrene, and other dihydrodiol deriva- tives of polycyclic aromatic hydrocarbons, Cancer Res., 49, 6304, 1989.
   Google Scholar
• Murray, G. I., Barnes, T. S., Sewell, H. F., Ewen, S. W. B., Melvin, W. T., and Burke, M. D., The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and ex- trahepatic tissues with a monoclonal antibody to hu- man cytochrome P-450, Br. J. Clin. Pharmacol., 25, 465, 1988.
   PubMed Web of Science ®Google Scholar
• Hukkanen, J., Lassila, A., Hakkola, J., Pelkonen, O., and Raunio, H., Induction of cytochrome P450 3A5 (CYP3A5) in human A549 lung adenocarcinoma cell line by anti-asthmatic glucocorticoids, 13th Inter- national Symposium on Microsomes and Drug Oxida- tions, 161, 2000, (Abstr.).
   Google Scholar
• Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., and VandenBranden, M., Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3), Mol. Pharmacol., 38, 207, 1990.
   PubMed Web of Science ®Google Scholar
• Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Korzekwa, K., Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s, Arch. Biochem. Biophys., 290, 160, 1991.
   PubMed Web of Science ®Google Scholar
• Westlind, A., Malmebo, S., Johansson, I., Otter, C., Andersson,T.B.,Ingelman-Sundberg,M.,andOscarson, M., Cloning and tissue distribution of a novel human cyto- chromeP450oftheCYP3Asubfamily,CYP3A43, Biochem. Biophys. Res. Commun., 281, 1349, 2001.
   PubMed Web of Science ®Google Scholar
• Domanski, T. L., Finta, C., Halpert, J. R., and Zaphiropoulos, P. G., cDNA cloning and initial char- acterization of CYP3A43, a novel human cytochrome P450, Mol. Pharmacol., 59, 386, 2001.
   PubMed Web of Science ®Google Scholar
• Imaoka, S., Asai, S., Sugimoto, T., Hiroi, T., and Funae, Y., Comparison of human CYP4B1 with that of other species, 11th International Conference on Cytochrome P450, 148, 1999, (Abstr.).
   Google Scholar
• Nhamburo, P. T., Gonzalez, F. J., McBride, O. W., Gelboin, H. V., and Kimura, S., Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromo- some mapping, Biochemistry, 28, 8060, 1989.
   Google Scholar
• Zheng, Y.-M., Fisher, M. B., Yokotani, N., Fujii- Kuriyama, Y., and Rettie, A. E., Identification of a meander region proline residue critical for heme bind- ing to cytochrome P450: implications for the catalytic function of human CYP4B1, Biochemistry, 37, 12847, 1998.
   Google Scholar
• Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T., and Funae, Y., CYP4B1 is a possible risk factor for bladder cancer in humans, Biochem. Biophys. Res. Commun., 277, 776, 2000.
   PubMed Web of Science ®Google Scholar
• Imaoka, S., Hayashi, K., Hiroi, T., Yabusaki, Y., Kamataki, T., and Funae, Y., A transgenic mouse expressing human CYP4B1 in the liver, Biochem. Biophys. Res. Commun., 284, 757, 2001.
   PubMed Web of Science ®Google Scholar
• Mastyugin, V., Aversa, E., Bonazzi, A., Vafaes, C., Mieyal, P., and Schwartzman, M. L., Hypoxia-in- duced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P- 4504B1 isoform, J. Pharmacol. Exp. Ther., 289, 1611, 1999.
   PubMed Web of Science ®Google Scholar
• Zhu, D., Birks, E. K., Dawson, C. A., Patel, M., Falck, J. R., Presberg, K., Roman, R. J., and Jacobs, E. R., Hypoxic pulmonary vasoconstriction is modi- fied by P-450 metabolites, Am. J. Physiol. Heart Circ. Physiol., 279, H1526–H1533, 2000.
   PubMed Web of Science ®Google Scholar
• Hall, P. d. l. M., Stupans, I., Burgess, W., Birkett, D. J., and McManus, M. E., Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues, Carcinogenesis, 10, 521, 1989.
   Google Scholar
• Anttila, S., Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Nurminen, T., and Vainio, H., Combined effect of CYP1A1 inducibility and GSTM1 polymorphism on histological type of lung cancer, Carcinogenesis, 15, 1133, 1994.
   PubMed Web of Science ®Google Scholar
• Saarikoski, S. T., Husgafvel-Pursiainen, K., Hirvonen, A., Vainio, H., Gonzalez, F. J., and Anttila, S., Localization of CYP1A1 mRNA in hu- man lung by in situ hybridization: comparison with immunohistochemical findings., Int. J. Cancer, 77, 33, 1998.
   Google Scholar
• Kikkawa, Y., Diverse role of pulmonary cytochrome P-450 monooxygenase, Lab. Invest., 67, 535, 1992.
   PubMed Web of Science ®Google Scholar
• Lumsden, A. B., McLean, A., and Lamb, D., Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers, Thorax, 39, 844, 1984.
   PubMed Web of Science ®Google Scholar
• Shijubo, N., Itoh, Y., Yamaguchi, T., Shibuya, Y., Morita, Y., Hirasawa, M., Okutani, R., Kawai, T., and Abe, S., Serum and BAL Clara cell 10kDa pro- tein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers, Eur. Resp. J., 10, 1108, 1997.
   PubMed Web of Science ®Google Scholar
• Roberts, E. A., Golas, C. L., and Okey, A. B., Ah receptor mediating induction of aryl hydrocarbon hydroxylase: detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin, Cancer Res., 46, 3739, 1986.
   Google Scholar
• Hayashi, S., Watanabe, J., Nakachi, K., Eguchi, H., Gotoh, O., and Kawajiri, K., Interindividual difference in expression of human Ah receptor and related P450 genes, Carcinogenesis, 15, 801, 1994.
   Google Scholar
• Anttila, S., Lei, X. D., Elovaara, E., Karjalainen, A., Sun, W., Vainio, H., and Hankinson, O., An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes, Pharmacoge- netics, 10, 741, 2000.
   Google Scholar
• Cantrell, E. T., Warr, G. A., Busbee, D. L., and Martin, R. R., Induction of aryl hydrocarbon hy- droxylase in human pulmonary alveolar macrophages by cigarette smoking, J. Clin. Invest., 52, 1881, 1973.
   PubMed Web of Science ®Google Scholar
• Murray, G. I., Melvin, W. T., Greenlee, W. F., and Burke, M. D., Regulation, function, and tissue-spe- cific expression of cytochrome P450 CYP1B1, Annu. Rev. Pharmacol. Toxicol., 41, 297, 2001.
   PubMed Web of Science ®Google Scholar
• Hellmann, G. M., Fields, W. R., and Doolittle, D. J., Gene expression profiling of cultured human bron- chial epithelial and lung carcinoma cells, Toxicol. Sci., 61, 154, 2001.
   PubMed Web of Science ®Google Scholar
• Waxman, D. J., P450 gene induction by structurally diverse xenochemicals: central role of nuclear recep- tors CAR, PXR, and PPAR, Arch. Biochem. Biophys., 369, 11, 1999.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Jounaidi, Y., Drocourt, L., Domergue, J., Balabaud, C., Maurel, P., and Vilarem, M.-J., Evidence for the presence of a func- tional pregnane X receptor response element in the CYP3A7 promoter gene, Biochem. Biophys. Res. Commun., 260, 377, 1999.
   PubMed Web of Science ®Google Scholar
• Pascussi, J.-M., Gerbal-Chaloin, S., Pichard- Garcia, L., Daujat, M., Fabre, J.-M., Maurel, P., and Vilarem, M.-J., Interleukin-6 negatively regu- lates the expression of pregnane X receptor and con- stitutively activated receptor in primary human hepa-tocytes, Biochem. Biophys. Res. Commun., 274, 707, 2000.
   PubMed Web of Science ®Google Scholar
• Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., and Evans, R. M., Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR, Genes Dev., 14, 3014, 2000.
   Google Scholar
• Gerbal-Chaloin, S., Pascussi, J.-M., Pichard- Garcia, L., Daujat, M., Waechter, F., Fabre, J.-M., Carrère, N., and Maurel, P., Induction of CYP2C genes in human hepatocytes in primary culture, Drug Metab. Dispos., 29, 242, 2001.
   PubMed Web of Science ®Google Scholar
• Blumberg, B., Sabbagh, W., Jr., Juguilon, H., Bolado, J., Jr., van Meter, C. M., Ong, E. S., and Evans, R. M., SXR, a novel steroid and xenobiotic- sensing nuclear receptor, Genes, 12, 3195, 1998.
   Google Scholar
• Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., and Kliewer, S. A., The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions, J. Clin. Invest., 102, 1016, 1998.
   PubMed Web of Science ®Google Scholar
• Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., and Berkenstam, A., Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction, Proc. Natl. Acad. Sci. USA, 95, 12208, 1998.
   PubMed Web of Science ®Google Scholar
• Baes, M., Gulick, T., Choi, H.-S., Martinoli, M. G., Simha, D., and Moore, D. D., A new orphan member of the nuclear hormone receptor superfamily that in- teracts with a subset of retinoic acid response ele- ments, Mol. Cell. Biol., 14, 1544, 1994.
   PubMed Web of Science ®Google Scholar
• Zelko, I. and Negishi, M., Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes, Biochem. Biophys. Res. Commun., 277, 1, 2000.
   PubMed Web of Science ®Google Scholar
• Bertilsson, G., Berkenstam, A., and Blomquist, P., Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7, Biochem. Biophys. Res. Commun., 280, 139, 2001.
   PubMed Web of Science ®Google Scholar
• Ohnhaus, E. E. and Bluhm, R. C., Induction of the monooxygenase enzyme system in human lung, Eur. J. Clin. Invest., 17, 488, 1987.
   PubMed Web of Science ®Google Scholar
• Yamazaki, H., Inoue, K., Mimura, M., Oda, Y., Guengerich, F. P., and Shimada, T., 7-ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes, Biochem. Pharmacol., 51, 313, 1996.
   PubMed Web of Science ®Google Scholar
• Yu, L. J., Matias, J., Scudiero, D. A., Hite, K. M., Monks, A., Sausville, E. A., and Waxman, D. J., P450 enzyme expression patterns in the NCI human tumor cell line panel, Drug Metab. Dispos., 29, 304, 2001.
   Google Scholar
• McLemore, T. L., Adelberg, S., Czerwinski, M., Hubbard, W. C., Yu, S. J., Storeng, R., Wood, T. G., Hines, R. N., and Boyd, M. R., Altered regula- tion of the cytochrome P4501A1 gene: novel inducer- independent gene expression in pulmonary carcinoma cell lines, J. Natl. Cancer Inst., 81, 1787, 1989.
   Google Scholar
• Stanley, L. A., Carmichael, J., and Wolf, C. R., Cytochrome P-450 induction in human lung tumor- derived cell lines: Characterisation and effects of in- flammatory mediators, Eur. J. Biochem., 208, 521, 1992.
   PubMedGoogle Scholar
• Vogel, C., Döhr, O., and Abel, J., Transforming growth factor-β1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells., Arch. Toxicol., 68, 303, 1994.
   PubMed Web of Science ®Google Scholar
• Döhr, O., Sinning, R., Vogel, C., Munzel, P., and Abel, J., Effect of transforming growth factor-β1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: cluesfor independent down-regula- tion in A549 cells, Mol. Pharmacol., 51, 703, 1997.
   PubMed Web of Science ®Google Scholar
• Foster, K. A., Oster, C. G., Mayer, M. M., Avery, M. L., and Audus, K. L., Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism, Exp. Cell. Res., 243, 359, 1998.
   PubMed Web of Science ®Google Scholar
• Urani, C., Doldi, M., Crippa, S., and Camatini, M., Human-derived cell lines to study xenobiotic metabo- lism, Chemosphere, 37, 2785, 1998.
   Google Scholar
• Ueng, T.-H., Hu, S.-H., Chen, R.-M., Wang, H.- W., and Kuo, M.-L., Induction of cytochrome P- 450 1A1 in human hepatoma HepG2 and lung carci- noma NCI-H322 cells by motorcycle exhaust particulate, J. Toxicol. Environ. Health, 60, 101, 2000.
   Google Scholar
• Hukkanen, J., Lassila, A., Päivärinta, K., Valanne, S., Sarpo, S., Hakkola, J., Pelkonen, O., and Raunio, H., Induction and regulation of xenobiotic-metaboliz- ing cytochrome P450s in the human A549 lung ad-enocarcinoma cell line, Am. J. Respir. Cell Mol. Biol., 22, 360, 2000.
   PubMed Web of Science ®Google Scholar
• Wang, H.-W., Chen, T.-L., Yang, P.-C., and Ueng, T.-H., Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5, Drug Metab. Dispos., 29, 1229, 2001.
   Google Scholar
• Offord, E. A., Macé, K., Ruffieux, C., Malnoë, A., and Pfeifer, A. M. A., Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bron- chial cells, Carcinogenesis, 16, 2057, 1995.
   Google Scholar
• Mollerup, S., Øvrebø, S., and Haugen, A., Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells, Int. J. Cancer, 92, 18, 2001.
   PubMed Web of Science ®Google Scholar
• Bonvallot, V., Baeza-Squiban, A., Baulig, A., Brulant, S., Boland, S., Muzeau, F., Barouki, R., and Marano, F., Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epi- thelial cells and induce cytochrome p450 1A1 expres- sion, Am. J. Respir. Cell Mol. Biol., 25, 515, 2001.
   PubMed Web of Science ®Google Scholar
• Ngui, J. S. and Bandiera, S. M., Induction of hepatic CYP2B is a more sensitive indicator of exposure to Aroclor 1260 than CYP1A in male rats, Toxicol. Appl. Pharmacol., 161, 160, 1999.
   PubMed Web of Science ®Google Scholar
• Hoet, P. H., Demedts, M., and Nemery, B., In vitro modulation of the P450 activities of hamster and hu- man lung slices, Cell Biol. Toxicol., 13, 185, 1997.
   PubMed Web of Science ®Google Scholar
• El Adlouni, C., Pinelli, E., Azémar, B., Zaoui, D., Beaune, P., and Pfohl-Leszkowicz, A., Phenobarbital increases DNA adduct and metabolites formed by och- ratoxin A: role of CYP 2C9 and microsomal glutathione- S-transferase, Environ. Mol. Mutagen., 35, 123, 2000.
   PubMed Web of Science ®Google Scholar